Whitepaper and App Notes
Measuring The Earliest Biomarkers Of Myocardial Injury And Risk Of Acute And Chronic Cardiac Disease
- Ultra-sensitive measurement of changes in baseline levels of cardiac troponin I (cTnI) for determining risk of Acute Coronary Syndrome
- Detection of natriuretic peptides (NT-proBNP) in monitoring chronic cardiac disease in COVID-19